BioMarin Submits VIMIZIM (elosulfase alfa) NDS to Health Canada for the Treatment of Morquio A Syndrome Under Priority Review Status
Posted by MyHealthShare, wordpress.com

See on Scoop.it – MyHealthShare Med­ical Reporter

Approval would deliv­er first treat­ment for Cana­di­ans liv­ing with ultra-rare, genet­ic meta­bol­ic dis­or­der.

See on online.wsj.com

BioMarin Submits VIMIZIM (elosulfase alfa) NDS to Health Canada for the Treatment of … | @scoopit http://flip.it/6F3Gm…@myhealthshare

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s